ATE417104T1 - G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen - Google Patents

G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen

Info

Publication number
ATE417104T1
ATE417104T1 AT00967335T AT00967335T ATE417104T1 AT E417104 T1 ATE417104 T1 AT E417104T1 AT 00967335 T AT00967335 T AT 00967335T AT 00967335 T AT00967335 T AT 00967335T AT E417104 T1 ATE417104 T1 AT E417104T1
Authority
AT
Austria
Prior art keywords
prostate cancer
protein
phor
coupled receptor
highly expressed
Prior art date
Application number
AT00967335T
Other languages
English (en)
Inventor
Arthur Raitano
Daniel Afar
Aya Jakobovits
Mary Faris
Rene Hubert
Steve Mitchell
Douglas Saffran
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Application granted granted Critical
Publication of ATE417104T1 publication Critical patent/ATE417104T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT00967335T 1999-10-05 2000-10-05 G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen ATE417104T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15790299P 1999-10-05 1999-10-05

Publications (1)

Publication Number Publication Date
ATE417104T1 true ATE417104T1 (de) 2008-12-15

Family

ID=22565799

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08165936T ATE524549T1 (de) 1999-10-05 2000-10-05 G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen
AT00967335T ATE417104T1 (de) 1999-10-05 2000-10-05 G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT08165936T ATE524549T1 (de) 1999-10-05 2000-10-05 G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen

Country Status (13)

Country Link
EP (2) EP1220913B1 (de)
JP (2) JP4272376B2 (de)
AT (2) ATE524549T1 (de)
AU (2) AU779685B2 (de)
CA (1) CA2385032C (de)
CY (2) CY1110059T1 (de)
DE (1) DE60041073D1 (de)
DK (2) DK2003202T3 (de)
ES (2) ES2371212T3 (de)
HK (1) HK1048494B (de)
IL (1) IL147952A0 (de)
PT (2) PT2003202E (de)
WO (1) WO2001025434A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790631B1 (en) 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof
US7361338B2 (en) 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
US20020048777A1 (en) 1999-12-06 2002-04-25 Shujath Ali Method of diagnosing monitoring, staging, imaging and treating prostate cancer
IL158860A0 (en) * 2001-05-15 2004-05-12 Agensys Inc Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer and pharmaceutical compositions containing the same
DK1864131T3 (da) * 2005-03-03 2011-10-31 Chemcom Sa Naturlig ligand af G protein koblet receptor RCC356 og anvendelser deraf
JPWO2007119515A1 (ja) * 2006-03-28 2009-08-27 昇志 佐藤 新規腫瘍抗原ペプチド
JP2012196211A (ja) * 2012-04-10 2012-10-18 Japan Science & Technology Agency 前立腺癌マーカポリペプチド、該ポリペプチドに対する抗体、及び該ポリペプチドを利用した前立腺癌の診断方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
EP0206448B1 (de) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hämoglobin, das an ein Poly(alkenylenoxid) gebunden ist
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US4975287A (en) 1989-09-01 1990-12-04 Wm. Wrigley Jr. Company Gum composition containing protein macrocolloids
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
DK0489149T3 (da) 1990-06-27 2001-12-27 Univ Princeton Prober til påvisning af mutant P53
US5733731A (en) 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
DE69532127T2 (de) 1994-07-20 2004-08-26 Genetics Institute, Inc., Cambridge Interaktions-fullensysteme zum nachweis von protein-interaktionen
US5919652A (en) 1994-11-09 1999-07-06 The Regents Of The University Of California Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
NZ306767A (en) 1995-04-11 2000-03-27 Univ Johns Hopkins Method of identifying molecular interactions employing counterselection and at least two hybrid molecules or two hybrid systems
CA2220979A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Human g-protein receptor hpraj70
CA2252886C (en) 1996-04-26 2008-02-12 Massachusetts Institute Of Technology Three-hybrid screening assay
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
JP2001502537A (ja) 1996-10-15 2001-02-27 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア ヒト前立腺ガンの進行の動物モデル
US5846722A (en) 1996-10-16 1998-12-08 Terrapin Technologies, Inc. System to detect small molecule/peptide interaction
CA2722378C (en) 1996-12-03 2015-02-03 Amgen Fremont Inc. Human antibodies that bind tnf.alpha.
JP2001512013A (ja) * 1997-08-01 2001-08-21 ジェンセット 前立腺に発現される分泌タンパク質の５’ｅｓｔ
HUP0203035A3 (en) * 1998-07-14 2007-12-28 Corixa Corp Compositions and methods for therapy and diagnosis of prostate cancer
CA2345045A1 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins
WO2000020590A2 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins

Also Published As

Publication number Publication date
EP2003202B1 (de) 2011-09-14
DE60041073D1 (de) 2009-01-22
EP1220913A1 (de) 2002-07-10
ES2316387T3 (es) 2009-04-16
CY1112202T1 (el) 2015-12-09
CA2385032C (en) 2013-12-10
AU779685B2 (en) 2005-02-03
HK1048494A1 (en) 2003-04-04
EP2003202A2 (de) 2008-12-17
EP1220913B1 (de) 2008-12-10
EP2003202A3 (de) 2009-10-21
HK1048494B (en) 2009-06-12
AU2005201916A2 (en) 2005-08-25
IL147952A0 (en) 2002-08-14
WO2001025434A1 (en) 2001-04-12
AU2005201916B2 (en) 2008-06-19
JP2009050256A (ja) 2009-03-12
PT1220913E (pt) 2009-02-16
ATE524549T1 (de) 2011-09-15
CY1110059T1 (el) 2015-01-14
PT2003202E (pt) 2012-01-02
JP4875671B2 (ja) 2012-02-15
CA2385032A1 (en) 2001-04-12
ES2371212T3 (es) 2011-12-28
DK2003202T3 (da) 2012-01-16
DK1220913T3 (da) 2009-03-16
AU2005201916A1 (en) 2005-06-02
JP4272376B2 (ja) 2009-06-03
JP2003511029A (ja) 2003-03-25
AU7755300A (en) 2001-05-10

Similar Documents

Publication Publication Date Title
EP1488007A4 (de) Verlaufsdarstellung der genexpression in bioptischen tumorgeweben
DK1228208T3 (da) 36P6D5: udskilt tumorantigen
MXPA02011142A (es) Plataforma de nanodispositivo multifuncional.
TR200102577T2 (tr) Kanser Tedavisi için Casb616 Polipeptid ve Polinücleotidlerin kullanımı
WO1998010069A3 (en) E25a protein, methods for production and use thereof
ATE364618T1 (de) Antikörper gegen das muc18-antigen
NO20015546D0 (no) Behandling av refrakt¶re humane tumorer med epidermale vekstfaktorreseptorantagonister
CY1110029T1 (el) Γονιδιο που εκφραζεται στον καρκινο του προστατη
ATE417104T1 (de) G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen
AU2003255820A8 (en) Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
WO2004031231A3 (en) Genes and polypeptides relating to prostate cancers
HUP0300054A1 (hu) Daganatspecifikus állati fehérjék
Trieb et al. Effects of hyperthermia on heat shock protein expression, alkaline phosphatase activity and proliferation in human osteosarcoma cells
ATE373711T1 (de) Gewebe-spezifische protein 103p2d6, hochexprimiert in verschiedene krebsarten
CN108794641A (zh) 一种针对EGFRvIII的多功能融合蛋白及其应用
WO2001090157A8 (en) 98p7c3: homeodomain protein highly expressed in various cancers
WO2002077234A3 (en) Compositions and methods relating to colon specific genes and proteins
DE60123285D1 (de) Säuger-krebszelle und menschliches protoonkogen tragender transgener säuger sowie kit zur krebsdiagnose mit dem protoonkogen
Lee et al. GHR106, the First in Class Antibody-based GnRH Antagonist for Broad Clinical Applications
WO2003025135A3 (en) Genes associated with malignant neoplasms
WO2002048370A3 (en) Compositions and methods relating to colon specific genes and proteins
GB0119791D0 (en) Proteins,genes and their use for diagnosis and treatment of breat cancer
Carlson COX 2: a promising target for chemotherapy
WO2002002598A3 (en) HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR18, AND USES THEROF
American Academy of Family Physicians Information from Your Family Doctor: Early Prostate Cancer: What You Should Know

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1220913

Country of ref document: EP